CFTR and non-Hodgkin lymphoma: Reduced CFTR expression and carrier status for CFTR mutation, even in people without a clinical diagnosis of CF, are recognized as risk factors for colorectal cancer (CRC), cancers of the gallbladder and biliary tract, thyroid cancer, and unspecified NHL [42,43,44].